TY - JOUR
T1 - Molecular Design for Dual Modulation Effect of Amyloid Protein Aggregation
AU - Zhu, Lijuan
AU - Song, Yang
AU - Cheng, Pin Nan
AU - Moore, Jeffrey S.
N1 - Publisher Copyright:
© 2015 American Chemical Society.
PY - 2015/7/1
Y1 - 2015/7/1
N2 - Modulation of protein self-assembly has been a powerful strategy for controlling and understanding amyloid protein aggregation. Most modulators of amyloid aggregation only involve simple inhibition or acceleration. Here we report a new multivalent molecular motif, the polyethylenimine-perphenazine (PEI-P) conjugate which has a dual "acceleration-inhibition" modulation effect on amyloid β (Aβ) aggregation. Dose dependent results from Thioflavin T fluorescence assays, circular dichroism, and atomic force microscopy show that PEI-P conjugates accelerate formation of Aβ prefibrillar intermediates and then inhibit Aβ fibrillation. Furthermore, compared to perphenazine alone, PEI-P conjugates exhibit an enhanced inhibitory effect due to multivalency. Cell viability assays indicate that the PEI-P conjugates reduce the cytotoxicity of Aβ aggregates in a dose-dependent manner. This new modulation strategy may shed light on controlling amyloid aggregation, which offers a general concept for designing new modulators. (Figure Presented).
AB - Modulation of protein self-assembly has been a powerful strategy for controlling and understanding amyloid protein aggregation. Most modulators of amyloid aggregation only involve simple inhibition or acceleration. Here we report a new multivalent molecular motif, the polyethylenimine-perphenazine (PEI-P) conjugate which has a dual "acceleration-inhibition" modulation effect on amyloid β (Aβ) aggregation. Dose dependent results from Thioflavin T fluorescence assays, circular dichroism, and atomic force microscopy show that PEI-P conjugates accelerate formation of Aβ prefibrillar intermediates and then inhibit Aβ fibrillation. Furthermore, compared to perphenazine alone, PEI-P conjugates exhibit an enhanced inhibitory effect due to multivalency. Cell viability assays indicate that the PEI-P conjugates reduce the cytotoxicity of Aβ aggregates in a dose-dependent manner. This new modulation strategy may shed light on controlling amyloid aggregation, which offers a general concept for designing new modulators. (Figure Presented).
UR - http://www.scopus.com/inward/record.url?scp=84934782869&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84934782869&partnerID=8YFLogxK
U2 - 10.1021/jacs.5b01651
DO - 10.1021/jacs.5b01651
M3 - Article
C2 - 26043045
AN - SCOPUS:84934782869
SN - 0002-7863
VL - 137
SP - 8062
EP - 8068
JO - Journal of the American Chemical Society
JF - Journal of the American Chemical Society
IS - 25
ER -